Home> Products> unique combination

{ "products": [ { "_id": "668bd2d4a00aac05f480d6e1", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HEALTHAMAZ HUNGER SYRUP ", "description": "HEALTHAMAZ HUNGER SYRUP \nCyproheptadine Hcl (2mg), Tricholine Citrate (275mg) & Sorbitol (2mg)Syrup\nOverview\nHEALTHAMAZ HUNGER SYRUP is a specially formulated syrup containing Cyproheptadine HCl (2mg), Tricholine Citrate (275mg), and Sorbitol (2mg) per dose. This combination is designed to stimulate appetite, aid in weight gain, and support overall digestive health.\n\nKey Ingredients\nCyproheptadine HCl (2mg): Cyproheptadine is an antihistamine with appetite-stimulating properties. It works by blocking histamine and serotonin receptors, which helps increase hunger and food intake.\nTricholine Citrate (275mg): Tricholine Citrate is a bile acid-binding agent that helps in reducing cholesterol levels and improving liver function. It supports fat metabolism and aids in detoxification.\nSorbitol (2mg): Sorbitol is a sugar alcohol that acts as a laxative and helps in alleviating constipation. It also serves as a sweetening agent, making the syrup palatable.\nUses\nAppetite Stimulation: HEALTHAMAZ HUNGER SYRUP is primarily used to increase appetite in individuals who struggle with poor food intake due to various conditions.\nWeight Gain: It helps underweight individuals and those recovering from illness to gain weight by enhancing their appetite and nutrient intake.\nDigestive Health: The syrup supports overall digestive health by improving liver function, aiding in fat metabolism, and alleviating constipation.\nDosage and Administration\nRecommended Dosage: The typical dosage for adults and children is as directed by a healthcare provider. It is usually taken before meals to stimulate appetite.\nAdministration: Shake the bottle well before use. Measure the prescribed amount using a dosing spoon or cup and consume the syrup directly. It can be taken with or without water.\nMechanism of Action\nCyproheptadine HCl: Increases appetite by blocking histamine and serotonin receptors, leading to enhanced hunger signals.\nTricholine Citrate: Improves liver function and aids in the metabolism of fats by increasing the secretion of bile acids.\nSorbitol: Acts as a mild laxative, promoting regular bowel movements and improving digestive comfort.\nSide Effects\nCommon Side Effects: Some common side effects include drowsiness, dizziness, dry mouth, and mild gastrointestinal disturbances such as nausea or stomach discomfort.\nSerious Side Effects: Rarely, serious side effects such as severe allergic reactions, confusion, and urinary retention may occur. Immediate medical attention is required if these symptoms develop.\nAllergic Reactions: Symptoms may include rash, itching, swelling, and difficulty breathin Discontinue use and seek medical attention if these symptoms develop.\nPrecautions\nMedical History: Inform your healthcare provider about your complete medical history, particularly if you have a history of asthma, glaucoma, stomach ulcers, or urinary problems.\nPregnancy and Breastfeeding: The safety of HEALTHAMAZ HUNGER SYRUP during pregnancy and breastfeeding has not been fully established. Consult your healthcare provider before use if you are pregnant or breastfeedin\nDrug Interactions: Cyproheptadine may interact with other medications such as sedatives, tranquilizers, and MAO inhibitors. Always inform your healthcare provider about all the medications and supplements you are taking to avoid adverse interactions.\nMonitoring\nRegular follow-up with your healthcare provider is recommended to monitor your response to the syrup and adjust the dosage if necessary. Keep track of any side effects and report them promptly.\n\nConclusion\nHEALTHAMAZ HUNGER SYRUP, with its blend of Cyproheptadine HCl, Tricholine Citrate, and Sorbitol, offers an effective solution for stimulating appetite, aiding weight gain, and supporting digestive health. By following the recommended dosage and taking necessary precautions, patients can achieve improved nutritional intake and overall well-bein Always consult your healthcare provider for personalized advice and treatment plans to ensure optimal benefits from this medication.\nFor further information \n Email: info@sterispharma.com / contact@sterispharma.com\n Call/WhatsApp: 7877551268, 7849827488\n BUY NOW\n\n", "price": 145.0, "discountamount": 44.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "dry mouth", "bile acids", "weight gain", "dosing spoon", "mild laxative", "sugar alcohol", "typical dosage", "fat metabolism", "MAO inhibitors", "stomach ulcers", "liver function", "Syrup Overview", "hunger signals", "treatment plans", "Key Ingredients", "nutrient intake", "optimal benefits", "urinary problems", "sweetening agent", "poor food intake", "other medications", "Drug Interactions", "urinary retention", "digestive comfort", "Regular follow-up", "overall well-bein", "Recommended Dosage", "Cyproheptadine Hcl", "effective solution", "stomach discomfort", "various conditions", "cholesterol levels", "Tricholine Citrate", "personalized advice", "healthcare provider", "serotonin receptors", "Common Side Effects", "Appetite Stimulation", "adverse interactions", "Serious Side Effects", "necessary precautions", "underweight individuals", "HEALTHAMAZ HUNGER SYRUP", "bile acid-binding agent", "regular bowel movements", "complete medical history", "overall digestive health", "severe allergic reactions", "Immediate medical attention", "improved nutritional intake", "appetite-stimulating properties", "mild gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 796, "imageuri": "https://bizimages.withfloats.com/actual/5115ea557be14015af293a26adb363f1.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/5115ea557be14015af293a26adb363f1.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-08T11:51:48.381Z", "updatedon": "2024-07-08T11:51:48.381Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/healthamaz-hunger-syrup-/796", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cyproheptadine Hcl (2mg), Tricholine Citrate (275mg) & Sorbitol (2mg)Syrup", "category": "General Range", "tags": [ "Cyproheptadine Hcl (2mg), Tricholine Citrate (275mg) & Sorbitol (2mg)Syrup", "Cyproheptadine Hydrochloride and Tricholine Citrate Syrup", "Cyproheptadine HCL Tricholine Citrate and Sorbitol Syrup uses", "Cyproheptadine hydrochloride Tricholine Citrate syrup dosage", "Cyproheptadine Hydrochloride Tricholine Citrate Sorbitol Syrup", "Cyproheptadine HCL Tricholine Citrate Sorbitol Syrup in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "668bd05613f4d41ef80a1771", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEFEXOTIME DICLOXA ", "description": "CEFEXOTIME DICLOXA \nCefixime (200mg), Dicloxacillin ER (500mg)\nOverview\nCEFEXOTIME DICLOXA combines two potent antibiotics, Cefixime (200mg) and Dicloxacillin ER (500mg), in an extended-release formulation. This medication is designed to treat a broad spectrum of bacterial infections by leveraging the complementary actions of both antibiotics to provide effective and sustained antibacterial activity.\n\nKey Ingredients\nCefixime (200mg): Cefixime is a third-generation cephalosporin antibiotic known for its broad-spectrum activity against Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death.\nDicloxacillin ER (500mg): Dicloxacillin is a penicillinase-resistant penicillin that is effective against penicillinase-producing staphylococci and other Gram-positive bacteria. The extended-release formulation allows for prolonged activity, ensuring sustained therapeutic levels in the body.\nUses\nRespiratory Tract Infections: CEFEXOTIME DICLOXA is effective in treating upper and lower respiratory tract infections, such as bronchitis, pneumonia, and tonsillitis.\nSkin and Soft Tissue Infections: The combination is used to manage skin infections, including cellulitis, impetigo, and abscesses caused by susceptible bacteria.\nUrinary Tract Infections: It is prescribed for urinary tract infections (UTIs) to eradicate the causative bacteria and relieve symptoms.\nBone and Joint Infections: This medication can be used to treat osteomyelitis and septic arthritis, offering a robust defense against bacterial infections in bones and joints.\nDosage and Administration\nRecommended Dosage: The typical dosage for adults is one tablet taken twice daily, or as directed by a healthcare provider. The extended-release formulation ensures a steady release of the medication over time.\nAdministration: The tablet should be swallowed whole with water. It is recommended to take it with food to enhance absorption and reduce the risk of gastrointestinal discomfort.\nMechanism of Action\nCefixime: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell death.\nDicloxacillin: Interferes with the synthesis of the bacterial cell wall by binding to penicillin-binding proteins, and its resistance to penicillinase ensures effectiveness against penicillinase-producing staphylococci.\nSide Effects\nCommon Side Effects: Some common side effects include gastrointestinal disturbances such as diarrhea, nausea, vomiting, and abdominal pain.\nSerious Side Effects: Rarely, it can cause severe allergic reactions, including anaphylaxis, severe skin reactions, and blood disorders. Immediate medical attention is required if these occur.\nAllergic Reactions: Symptoms may include rash, itching, swelling, and difficulty breathin Discontinue use and seek medical attention if these symptoms develop.\nPrecautions\nMedical History: Inform your healthcare provider about your complete medical history, particularly if you have a history of allergies to antibiotics, kidney disease, or liver disease.\nPregnancy and Breastfeeding: The safety of CEFEXOTIME DICLOXA during pregnancy and breastfeeding has not been fully established. Consult your healthcare provider before use if you are pregnant or breastfeedin\nDrug Interactions: This medication may interact with other drugs, such as anticoagulants and oral contraceptives. Always inform your healthcare provider about all the medications and supplements you are taking to avoid adverse interactions.\nMonitoring\nRegular monitoring of kidney and liver function is recommended during prolonged therapy. Additionally, periodic assessment of blood counts may be necessary to detect any potential hematologic side effects.\n\nConclusion\nCEFEXOTIME DICLOXA, combining Cefixime (200mg) and Dicloxacillin ER (500mg), provides a powerful and extended-release solution for treating a wide range of bacterial infections. Its dual-action mechanism ensures broad-spectrum efficacy, making it a versatile option for healthcare providers. Regular monitoring and adherence to prescribed dosages are essential for achieving optimal therapeutic outcomes. Always consult your healthcare provider for personalized advice and treatment plans.\n For further information \n Email: info@sterispharma.com / contact@sterispharma.com\n Call/WhatsApp: 7877551268, 7849827488\n BUY NOW\n", "price": 395.0, "discountamount": 119.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "one tablet", "wide range", "cell death", "cell lysis", "other drugs", "blood counts", "liver disease", "kidney disease", "typical dosage", "liver function", "abdominal pain", "steady release", "robust defense", "broad spectrum", "treatment plans", "blood disorders", "Key Ingredients", "skin infections", "Dicloxacillin ER", "versatile option", "septic arthritis", "Joint Infections", "prolonged therapy", "Drug Interactions", "Regular monitoring", "Recommended Dosage", "prescribed dosages", "CEFEXOTIME DICLOXA", "causative bacteria", "prolonged activity", "personalized advice", "periodic assessment", "oral contraceptives", "healthcare provider", "Common Side Effects", "adverse interactions", "susceptible bacteria", "bacterial infections", "Serious Side Effects", "dual-action mechanism", "complementary actions", "severe skin reactions", "Gram-negative bacteria", "two potent antibiotics", "Soft Tissue Infections", "broad-spectrum efficacy", "broad-spectrum activity", "complete medical history", "Urinary Tract Infections", "extended-release solution", "severe allergic reactions", "penicillin-binding proteins", "gastrointestinal discomfort", "Immediate medical attention", "extended-release formulation", "other Gram-positive bacteria", "optimal therapeutic outcomes", "sustained therapeutic levels", "gastrointestinal disturbances", "bacterial cell wall synthesis", "sustained antibacterial activity", "penicillinase-resistant penicillin", "lower respiratory tract infections", "potential hematologic side effects", "penicillinase-producing staphylococci", "third-generation cephalosporin antibiotic" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 795, "imageuri": "https://bizimages.withfloats.com/actual/59947a8508a24777b8b99922d6569d5c.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/59947a8508a24777b8b99922d6569d5c.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-08T11:41:10.712Z", "updatedon": "2024-07-08T11:41:10.712Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/cefexotime-dicloxa-/795", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Cefixime (200mg), Dicloxacillin ER (500mg)", "category": "General Range", "tags": [ "Cefixime and dicloxacillin er tablets uses in hindi", "Cefixime and Dicloxacillin tablets side effects", "Cefixime and dicloxacillin extended release tablets uses", "Cefixime Dicloxacillin and lactic acid bacillus tablets uses", "Cefixime+Dicloxacillin er tablets", "Cefixime Dicloxacillin and lactic acid bacillus tablets Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "668bcda87593631e4c0856cc", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIVESTIN TABLETS ", "description": "STERIVESTIN TABLETS \nScutellaria Baicalensis and Acacia Catechu\nOverview\nSTERIVESTIN TABLETS contain a unique blend of Scutellaria Baicalensis and Acacia Catechu, two powerful herbal ingredients known for their various health benefits. This formulation is designed to support overall health, providing antioxidant, anti-inflammatory, and immune-boosting properties.\n\nKey Ingredients\nScutellaria Baicalensis: Also known as Chinese Skullcap, this herb is renowned for its anti-inflammatory and antioxidant properties. It has been used in traditional Chinese medicine for centuries to treat various ailments, including infections, allergies, and inflammatory conditions.\nAcacia Catechu: Commonly known as Black Catechu, this herb is valued for its astringent and anti-inflammatory effects. It has a long history of use in traditional medicine for treating digestive issues, respiratory conditions, and skin problems.\nUses\nAnti-inflammatory Support: STERIVESTIN TABLETS help reduce inflammation throughout the body, making them beneficial for conditions such as arthritis, allergies, and other inflammatory disorders.\nAntioxidant Protection: The powerful antioxidants in Scutellaria Baicalensis and Acacia Catechu help protect the body’s cells from damage caused by free radicals, supporting overall health and well-being.\nImmune System Boost: The immune-boosting properties of these herbs enhance the body's natural defenses, helping to ward off infections and illnesses.\nDigestive Health: Acacia Catechu supports digestive health by providing relief from gastrointestinal discomfort and promoting a healthy digestive system.\nRespiratory Health: Both herbs have been traditionally used to support respiratory health, helping to alleviate symptoms of respiratory infections and conditions such as bronchitis and asthma.\nDosage and Administration\nRecommended Dosage: The typical dosage for STERIVESTIN TABLETS is one to two tablets daily, taken with water. However, it is essential to follow the dosage instructions provided by your healthcare provider.\nAdministration: The tablets should be taken with meals to enhance absorption and minimize the risk of gastrointestinal discomfort.\nSide Effects\nCommon Side Effects: STERIVESTIN TABLETS are generally well-tolerated. However, some individuals may experience mild side effects such as gastrointestinal discomfort, nausea, or headache.\nSerious Side Effects: Rarely, allergic reactions such as rash, itching, swelling, or difficulty breathing may occur. Discontinue use and seek medical attention if these symptoms develop.\nPrecautions\nMedical History: Inform your healthcare provider about your complete medical history, particularly if you have any known allergies, digestive disorders, or chronic health conditions.\nPregnancy and Breastfeeding: The safety of STERIVESTIN TABLETS during pregnancy and breastfeeding has not been established. Consult your healthcare provider before use if you are pregnant or breastfeeding.\nDrug Interactions: There is a potential for interactions with other medications or supplements. Always inform your healthcare provider about all the products you are taking to avoid adverse interactions.\nConclusion\nSTERIVESTIN TABLETS, containing Scutellaria Baicalensis and Acacia Catechu, offer a natural way to support overall health with their potent anti-inflammatory, antioxidant, and immune-boosting properties. By incorporating these herbal ingredients, STERIVESTIN TABLETS can help manage inflammation, protect against oxidative stress, enhance immune function, and promote digestive and respiratory health.\nFor further information \n Email: info@sterispharma.com / contact@sterispharma.com\n Call/WhatsApp: 7877551268, 7849827488\n BUY NOW\n", "price": 545.0, "discountamount": 164.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "natural way", "unique blend", "long history", "free radicals", "skin problems", "Black Catechu", "typical dosage", "overall health", "immune function", "Key Ingredients", "oxidative stress", "natural defenses", "digestive issues", "Digestive Health", "various ailments", "Chinese Skullcap", "Drug Interactions", "medical attention", "other medications", "mild side effects", "Recommended Dosage", "allergic reactions", "Respiratory Health", "dosage instructions", "healthcare provider", "STERIVESTIN TABLETS", "digestive disorders", "Common Side Effects", "Immune System Boost", "adverse interactions", "traditional medicine", "Serious Side Effects", "powerful antioxidants", "respiratory infections", "respiratory conditions", "Antioxidant Protection", "antioxidant properties", "Scutellaria Baicalensis", "inflammatory conditions", "Acacia Catechu Overview", "various health benefits", "complete medical history", "healthy digestive system", "one to two tablets daily", "Anti-inflammatory Support", "anti-inflammatory effects", "chronic health conditions", "immune-boosting properties", "gastrointestinal discomfort", "other inflammatory disorders", "traditional Chinese medicine", "two powerful herbal ingredients" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 794, "imageuri": "https://bizimages.withfloats.com/actual/65d19e98e46b453fbd90603a196e2e54.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/65d19e98e46b453fbd90603a196e2e54.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-08T11:29:44.365Z", "updatedon": "2024-07-08T11:29:44.365Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/sterivestin-tablets-/794", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Scutellaria Baicalensis and Acacia Catechu", "category": "General Range", "tags": [ "Scutellaria baicalensis and Acacia catechu Tablets uses in hindi", "Scutellaria baicalensis common name", "Scutellaria baicalensis and Acacia catechu uses", "Scutellaria baicalensis Hindi name", "Scutellaria baicalensis and Acacia catechu side effects", "Scutellaria baicalensis in India", "Scutellaria baicalensis Ayurvedic name", "Acacia catechu common name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "668bcd370ba9941edc1e1dd9", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIHEAL DISPERSIBLE ", "description": "STERIHEAL DISPERSIBLE \nTrypsin Bp (96mg) , Bromelain (180mg) & Rutoside Trihydrate Bp (200mg)\nOverview\nSTERIHEAL DISPERSIBLE tablets combine three potent ingredients: Trypsin BP (96mg), Bromelain (180mg), and Rutoside Trihydrate BP (200mg). This formulation is designed to provide powerful anti-inflammatory and proteolytic effects, aiding in the treatment of inflammation, swelling, and pain associated with various medical conditions.\n\nKey Ingredients\nTrypsin BP: Trypsin is a proteolytic enzyme that helps in breaking down proteins into smaller peptides. It has been used in medical treatments to reduce inflammation and promote wound healin\nBromelain: Extracted from pineapples, Bromelain is another proteolytic enzyme known for its anti-inflammatory and analgesic properties. It aids in reducing pain and swelling, particularly in conditions involving soft tissue injuries.\nRutoside Trihydrate BP: Also known as Rutin, this bioflavonoid has strong antioxidant properties and helps strengthen blood vessels, reducing capillary fragility and permeability. It also exhibits anti-inflammatory effects.\nUses\nInflammation and Swelling: STERIHEAL DISPERSIBLE is highly effective in reducing inflammation and swelling associated with various conditions, including post-surgical recovery, trauma, and soft tissue injuries.\nPain Management: The combination of Trypsin, Bromelain, and Rutoside helps alleviate pain, making it useful for conditions like arthritis, sprains, and strains.\nWound Healing: Trypsin promotes the breakdown of necrotic tissue, enhancing the healing process of wounds and ulcers.\nBlood Circulation: Rutoside strengthens blood vessels and improves circulation, reducing the risk of bruising and varicose veins.\nDosage and Administration\nRecommended Dosage: The typical dosage for STERIHEAL DISPERSIBLE is one to two tablets daily, or as prescribed by a healthcare provider.\nAdministration: The tablets are dispersible and should be dissolved in water before consumption. This form ensures rapid absorption and quick relief from symptoms.\nMechanism of Action\nTrypsin: Works by breaking down proteins into smaller peptides, which helps in the removal of dead tissue and promotes new tissue growth.\nBromelain: Inhibits the production of pro-inflammatory compounds and helps in the breakdown of fibrin, reducing edema and pain.\nRutoside: Stabilizes and strengthens capillaries, reducing capillary permeability and preventing leakage of blood into tissues.\nSide Effects\nCommon Side Effects: STERIHEAL DISPERSIBLE is generally well-tolerated. Some individuals may experience mild gastrointestinal disturbances such as nausea, diarrhea, or stomach cramps.\nSerious Side Effects: Rarely, allergic reactions such as rash, itching, swelling, or difficulty breathing may occur. Discontinue use and seek medical attention if these symptoms develop.\nPrecautions\nMedical History: Inform your healthcare provider about your complete medical history, particularly if you have any known allergies, digestive disorders, or bleeding disorders.\nPregnancy and Breastfeeding: The safety of STERIHEAL DISPERSIBLE during pregnancy and breastfeeding has not been established. Consult your healthcare provider before use if you are pregnant or breastfeedin\nDrug Interactions: There is a potential for interactions with other medications or supplements, especially anticoagulants and antiplatelet drugs. Always inform your healthcare provider about all the products you are taking to avoid adverse interactions.\nConclusion\nSTERIHEAL DISPERSIBLE, with its potent combination of Trypsin BP, Bromelain, and Rutoside Trihydrate BP, offers a comprehensive solution for managing inflammation, pain, and swellin Its dispersible form ensures quick and effective relief, promoting faster recovery and improved well-bein Regular use as part of a balanced treatment plan can significantly enhance the healing process and overall health.\nFor further information \n Email: info@sterispharma.com / contact@sterispharma.com\n Call/WhatsApp: 7877551268, 7849827488\n BUY NOW\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "Trypsin Bp", "Regular use", "dead tissue", "quick relief", "wound healin", "blood vessels", "typical dosage", "overall health", "stomach cramps", "varicose veins", "Pain Management", "faster recovery", "healing process", "Key Ingredients", "necrotic tissue", "dispersible form", "effective relief", "rapid absorption", "smaller peptides", "Blood Circulation", "Drug Interactions", "other medications", "medical attention", "new tissue growth", "Recommended Dosage", "potent combination", "antiplatelet drugs", "bleeding disorders", "allergic reactions", "proteolytic enzyme", "various conditions", "medical treatments", "one to two tablets", "digestive disorders", "healthcare provider", "capillary fragility", "proteolytic effects", "Common Side Effects", "adverse interactions", "analgesic properties", "Serious Side Effects", "soft tissue injuries", "capillary permeability", "comprehensive solution", "post-surgical recovery", "Rutoside Trihydrate Bp", "balanced treatment plan", "complete medical history", "three potent ingredients", "anti-inflammatory effects", "powerful anti-inflammatory", "pro-inflammatory compounds", "various medical conditions", "STERIHEAL DISPERSIBLE tablets", "strong antioxidant properties", "mild gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 793, "imageuri": "https://bizimages.withfloats.com/actual/4ce1cd8775cb4954aafd4793d873f9f5.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/4ce1cd8775cb4954aafd4793d873f9f5.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-08T11:27:51.292Z", "updatedon": "2024-07-08T11:27:51.292Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/steriheal-dispersible-/793", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Trypsin Bp (96mg) , Bromelain (180mg) & Rutoside Trihydrate Bp (200mg)", "category": "Orthopedics", "tags": [ "Trypsin Bromelain Rutoside Trihydrate Tablets Uses in hindi", "Trypsin Bromelain Rutoside Trihydrate Tablets Price", "Trypsin Bromelain Rutoside Trihydrate and Diclofenac Sodium Tablets", "Trypsin, Bromelain Rutoside Trihydrate side effects", "Trypsin, Bromelain Rutoside Trihydrate dosage", "Trypsin Bromelain Rutoside Trihydrate tablets uses in" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "668002ef44c20b1658b8d409", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RISPERITIME PLUS ", "description": "RISPERITIME PLUS \nRisperidone (2mg), Trihexyphenidyl (2mg)\nIntroduction\nRISPERITIME PLUS is a combination medication that contains Risperidone (2mg) and Trihexyphenidyl (2mg). It is primarily used to manage and treat various psychiatric and neurological conditions. This article provides a comprehensive overview of RISPERITIME PLUS, including its uses, benefits, dosage, potential side effects, and precautions.\n\nUses and Benefits\nRISPERITIME PLUS is prescribed for the treatment of several disorders, including:\n\nSchizophrenia: Helps reduce symptoms such as hallucinations, delusions, and disorganized thinkin Risperidone is effective in improving concentration and reducing episodes of aggression or agitation.\nBipolar Disorder: Effective in managing manic episodes. It helps stabilize mood swings and prevent relapses.\nParkinsonism Symptoms in Psychiatric Patients: Trihexyphenidyl helps manage extrapyramidal symptoms (movement disorders) caused by antipsychotic medications like Risperidone.\nMechanism of Action\nRisperidone\n\nWorks by modulating the activity of neurotransmitters in the brain, particularly serotonin and dopamine. It acts on multiple receptor types, helping balance the chemicals in the brain associated with mood, behavior, and perception.\nTrihexyphenidyl\n\nActs as an anticholinergic agent, helping to reduce the activity of acetylcholine in the brain. This reduces muscle stiffness, tremors, and other extrapyramidal symptoms caused by antipsychotic medications.\nDosage and Administration\n\nThe typical starting dose of RISPERITIME PLUS is one tablet taken once or twice daily, depending on the severity of symptoms and the patient’s response.\nIt is crucial to follow the prescribed dosage and not to alter or discontinue the medication without consulting a healthcare professional.\nRISPERITIME PLUS can be taken with or without food.\nPossible Side Effects\nLike any medication, RISPERITIME PLUS may cause side effects. Common side effects include:\n\nDrowsiness: A sedative effect that can help with sleep issues but may cause daytime drowsiness.\nDry Mouth: A common side effect that can be managed by staying hydrated and using sugar-free gum or lozenges.\nWeight Gain: Monitoring diet and exercise can help manage this side effect.\nDizziness: Especially when getting up from a sitting or lying position.\nMore serious side effects, though less common, include:\n\nOrthostatic Hypotension: A drop in blood pressure upon standing, which may cause dizziness or faintin\nIncreased Blood Sugar Levels: Regular monitoring of blood glucose levels is recommended, especially for diabetic patients.\nExtrapyramidal Symptoms: Although Trihexyphenidyl helps manage these symptoms, they can still occur, especially if the medication is not taken as prescribed.\nPrecautions and Contraindications\n\nBefore starting RISPERITIME PLUS, inform your healthcare provider about any pre-existing medical conditions, especially heart problems, diabetes, liver issues, or a history of seizures.\nAvoid alcohol while taking this medication, as it can exacerbate side effects such as drowsiness and dizziness.\nPregnant or breastfeeding women should consult their doctor before using RISPERITIME PLUS, as its safety in pregnancy and lactation has not been fully established.\nInteractions with Other Medications\n\nRISPERITIME PLUS can interact with other medications, including antihypertensives, antidepressants, and antifungal drugs. It is essential to provide a complete list of all medications and supplements being taken to the healthcare provider to avoid potential interactions.\nConclusion\nRISPERITIME PLUS (Risperidone 2mg, Trihexyphenidyl 2mg) is a versatile medication used to treat various psychiatric and neurological conditions, including schizophrenia, bipolar disorder, and drug-induced parkinsonism. By balancing neurotransmitter activity and reducing extrapyramidal symptoms, it helps alleviate symptoms and improve the quality of life for patients. Adherence to the prescribed dosage, awareness of potential side effects, and regular consultation with a healthcare provider are essential for effective management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/risperitime-plus-134326", "price": 65.0, "discountamount": 20.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "drop", "diet", "life", "food", "Acts", "uses", "EMAIL", "brain", "safety", "doctor", "article", "faintin", "history", "alcohol", "sitting", "tremors", "quality", "behavior", "lozenges", "dopamine", "relapses", "benefits", "response", "severity", "exercise", "standing", "diabetes", "seizures", "Pregnant", "Dry Mouth", "treatment", "delusions", "agitation", "Mechanism", "awareness", "serotonin", "Dizziness", "Adherence", "lactation", "pregnancy", "chemicals", "Conclusion", "perception", "aggression", "one tablet", "supplements", "information", "Weight Gain", "mood swings", "precautions", "disorganized", "sterispharma", "Introduction", "sterisonline", "liver issues", "sleep issues", "complete list", "CALL/WHATSAPP", "concentration", "acetylcholine", "Schizophrenia", "lying position", "heart problems", "sugar-free gum", "manic episodes", "blood pressure", "Administration", "hallucinations", "Risperidone 2mg", "sedative effect", "antidepressants", "Bipolar Disorder", "RISPERITIME PLUS", "antifungal drugs", "muscle stiffness", "several disorders", "Contraindications", "neurotransmitters", "diabetic patients", "Other Medications", "Risperidone Works", "antihypertensives", "prescribed dosage", "movement disorders", "Regular monitoring", "daytime drowsiness", "healthcare provider", "breastfeeding women", "Trihexyphenidyl 2mg", "various psychiatric", "thinkin Risperidone", "Common side effects", "Psychiatric Patients", "blood glucose levels", "versatile medication", "regular consultation", "effective management", "anticholinergic agent", "typical starting dose", "Parkinsonism Symptoms", "Possible Side Effects", "combination medication", "comprehensive overview", "potential interactions", "potential side effects", "multiple receptor types", "Orthostatic Hypotension", "neurological conditions", "healthcare professional", "neurotransmitter activity", "antipsychotic medications", "drug-induced parkinsonism", "More serious side effects", "existing medical conditions", "Increased Blood Sugar Levels", "other extrapyramidal symptoms" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 785, "imageuri": "https://bizimages.withfloats.com/actual/3f80f63431364ed2b0f9115bd4dd1458.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/3f80f63431364ed2b0f9115bd4dd1458.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-29T12:49:51.845Z", "updatedon": "2024-06-29T12:49:51.845Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/risperitime-plus-/785", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Risperidone (2mg), Trihexyphenidyl (2mg)", "category": "Neurology Range", "tags": [ "Risperidone and Trihexyphenidyl Tablets Uses in Hindi", "risperidone + trihexyphenidyl combination brand name", "Risperidone and trihexyphenidyl hydrochloride tablet uses in", "Risperidone and Trihexyphenidyl Hydrochloride Tablets Price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "667eb6d91ca77d1a60e632e5", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP DAPA 5-10 ", "description": "LINALIGLIP DAPA 5-10 \nLinagliptin 5 mg & Dapagliflozin 10 mg\nIntroduction:\nDiabetes mellitus poses a significant public health challenge, with its prevalence continuing to rise globally. In the quest for effective management strategies, the combination of multiple therapeutic agents with complementary mechanisms of action has gained traction. LINALIGLIP DAPA 5-10, a novel formulation combining Linagliptin 5 mg and Dapagliflozin 10 mg, represents a groundbreaking approach to diabetes care. This article explores the synergistic benefits, efficacy, and clinical implications of LINALIGLIP DAPA 5-10 in the management of type 2 diabetes mellitus (T2DM).\n\nUnderstanding the Mechanisms of Action:\nLINALIGLIP DAPA 5-10 combines two distinct classes of antidiabetic medications: Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. Linagliptin enhances the activity of incretin hormones, such as glucagon-like peptide-1 (GLP-1), promoting insulin secretion and suppressing glucagon release. Dapagliflozin, on the other hand, inhibits renal glucose reabsorption, leading to increased urinary glucose excretion and subsequent lowering of blood glucose levels. By targeting different pathways involved in glucose regulation, LINALIGLIP DAPA 5-10 offers a comprehensive approach to glycemic control.\n\nSynergistic Benefits:\nThe combination of Linagliptin and Dapagliflozin in LINALIGLIP DAPA 5-10 provides several synergistic benefits. Firstly, the dual action of these agents targets multiple aspects of glucose homeostasis, resulting in greater reductions in hemoglobin A1c (HbA1c) levels compared to monotherapy with either component alone. Secondly, Dapagliflozin's mechanism of action leads to diuretic effects, reducing blood pressure and promoting weight loss, which complements the glucose-lowering effects of Linagliptin. Finally, the combination therapy may offer cardiovascular and renal protective benefits, as suggested by clinical trials evaluating SGLT2 inhibitors.\n For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now:\nhttps://www.sterisonline.com/product/linaliglip-dapa-5-10-134320\n", "price": 245.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "GLP", "T2DM", "Email", "quest", "article", "traction", "activity", "efficacy", "WhatsApp", "component", "peptide-1", "prevalence", "other hand", "monotherapy", "information", "dual action", "weight loss", "sterispharma", "Introduction", "sterisonline", "HbA1c) levels", "transporter 2", "diabetes care", "Dapagliflozin", "cardiovascular", "sodium-glucose", "hemoglobin A1c", "blood pressure", "clinical trials", "LINALIGLIP DAPA", "Linagliptin 5 mg", "glycemic control", "SGLT2) inhibitor", "glucagon release", "diuretic effects", "multiple aspects", "DPP-4) inhibitor", "SGLT2 inhibitors", "novel formulation", "insulin secretion", "incretin hormones", "glucose regulation", "greater reductions", "different pathways", "glucose homeostasis", "combination therapy", "subsequent lowering", "two distinct classes", "blood glucose levels", "clinical implications", "dipeptidyl peptidase-4", "comprehensive approach", "groundbreaking approach", "type 2 diabetes mellitus", "antidiabetic medications", "complementary mechanisms", "glucose-lowering effects", "renal protective benefits", "urinary glucose excretion", "renal glucose reabsorption", "multiple therapeutic agents", "several synergistic benefits", "effective management strategies", "significant public health challenge" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 777, "imageuri": "https://bizimages.withfloats.com/actual/1f723dbe4c0848739629bd724e08ca1a.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/1f723dbe4c0848739629bd724e08ca1a.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-28T13:12:57.256Z", "updatedon": "2024-06-28T13:12:57.256Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/linaliglip-dapa-5-10-/777", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Linagliptin 5 mg & Dapagliflozin 10 mg", "category": "Diabetic Range", "tags": [ "Daplo-L", "Dapaone L", "Dapanova L", "Dapagza L", "Linalent-D", "Linahenz D", "Dajio L", "Linamac D", "Linapil-D", "Ondero-D" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "667eb56f8e97fb17d8076332", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP 2.5/500 ", "description": "LINALIGLIP 2.5/500 \nLinagliptin & Metformin Hydrochloride\nIntroduction:\nThe management of type 2 diabetes mellitus (T2DM) often necessitates a multifaceted approach, combining lifestyle modifications, dietary interventions, and pharmacotherapy. Among the pharmacological agents commonly prescribed for T2DM, both Linagliptin and Metformin Hydrochloride stand out for their efficacy and safety profiles. The combination of these two medications in LINALIGLIP 2.5/500 offers a synergistic approach to glycemic control. This article explores the rationale behind combining Linagliptin and Metformin Hydrochloride, their individual mechanisms of action, and the clinical implications of LINALIGLIP 2.5/500 in the management of T2DM.\n\nUnderstanding the Components:\nLINALIGLIP 2.5/500 comprises two active ingredients: Linagliptin and Metformin Hydrochloride. Linagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, which enhance the activity of incretin hormones, such as glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and suppressing glucagon release. Metformin Hydrochloride, on the other hand, is a biguanide that primarily works by reducing hepatic glucose production, improving insulin sensitivity, and decreasing intestinal glucose absorption.\n\nSynergistic Mechanisms of Action:\nThe combination of Linagliptin and Metformin Hydrochloride in LINALIGLIP 2.5/500 capitalizes on their complementary mechanisms of action. Linagliptin enhances insulin secretion and suppresses glucagon release, primarily targeting postprandial glucose excursions. Meanwhile, Metformin Hydrochloride reduces hepatic glucose output, improves insulin sensitivity, and enhances peripheral glucose uptake, primarily addressing fasting hyperglycemia. Together, these medications offer comprehensive glycemic control, targeting both fasting and postprandial glucose levels.\n\nEfficacy in Glycemic Control:\nClinical studies have demonstrated the efficacy of LINALIGLIP 2.5/500 in improving glycemic control in patients with T2DM. The combination therapy has been shown to reduce hemoglobin A1c (HbA1c) levels to a greater extent than either Linagliptin or Metformin Hydrochloride alone. Additionally, the dual-action approach of LINALIGLIP 2.5/500 offers advantages in terms of durability and sustainability of glycemic control over the long term, thereby reducing the risk of diabetes-related complications.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now:\n\nhttps://www.sterisonline.com/product/linaliglip-2-5-500-134273\n", "price": 255.0, "discountamount": 76.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "Call", "risk", "T2DM", "Email", "class", "terms", "GLP-1", "article", "fasting", "patients", "efficacy", "activity", "WhatsApp", "rationale", "biguanide", "long term", "advantages", "durability", "Components", "other hand", "management", "Linagliptin", "information", "Introduction", "sterisonline", "sterispharma", "HbA1c) levels", "hyperglycemia", "sustainability", "hemoglobin A1c", "greater extent", "safety profiles", "two medications", "pharmacotherapy", "Clinical studies", "glucagon release", "DPP-4) inhibitors", "insulin secretion", "incretin hormones", "LINALIGLIP 2.5/500", "insulin sensitivity", "combination therapy", "synergistic approach", "dual-action approach", "clinical implications", "individual mechanisms", "dietary interventions", "multifaceted approach", "dipeptidyl peptidase-4", "hepatic glucose output", "Synergistic Mechanisms", "pharmacological agents", "two active ingredients", "Metformin Hydrochloride", "lifestyle modifications", "glucagon-like peptide-1", "complementary mechanisms", "type 2 diabetes mellitus", "peripheral glucose uptake", "hepatic glucose production", "postprandial glucose levels", "intestinal glucose absorption", "comprehensive glycemic control", "diabetes-related complications", "postprandial glucose excursions" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 775, "imageuri": "https://bizimages.withfloats.com/actual/5632c12dc8ca473884f673664a23f6eb.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/5632c12dc8ca473884f673664a23f6eb.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-28T13:06:55.073Z", "updatedon": "2024-06-28T13:06:55.073Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/linaliglip-2-5-500-/775", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Linagliptin & Metformin Hydrochloride", "category": "Diabetic Range", "tags": [ "Trajenta Duo", "Ondero Met", "Linapil-M", "Linaglite M", "Saiumet L", "Ligotil-M", "Nexolina M", "Glylina-M", "Diablin M", "Linanext-M" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "667eb527a0b09b04e07d172c", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP M 5/500 ", "description": "LINALIGLIP M 5/500 \nLinagliptin 5mg and Metformin Hydrochloride (SR) 500mg\nIntroduction:\nType 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance and impaired glucose regulation. In the pursuit of effective treatment strategies, combination therapies have emerged as valuable tools for achieving optimal glycemic control while minimizing the risk of adverse effects. LINALIGLIP M 5/500, a formulation containing Linagliptin 5 mg and Metformin Hydrochloride (sustained-release) 500 mg, embodies this approach by combining two proven antidiabetic agents with complementary mechanisms of action. This article delves into the rationale behind the combination, the individual contributions of Linagliptin and Metformin Hydrochloride, and the clinical implications of LINALIGLIP M 5/500 in the management of T2DM.\n\nUnderstanding the Components:\nLINALIGLIP M 5/500 integrates two key components: Linagliptin and Metformin Hydrochloride (SR). Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, works by enhancing the activity of incretin hormones, such as glucagon-like peptide-1 (GLP-1), thereby stimulating insulin secretion and suppressing glucagon release. Metformin Hydrochloride, a biguanide, primarily acts by reducing hepatic glucose production, increasing peripheral glucose uptake, and improving insulin sensitivity, thus addressing both fasting and postprandial hyperglycemia.\n\nSynergistic Mechanisms of Action:\nThe combination of Linagliptin and Metformin Hydrochloride in LINALIGLIP M 5/500 capitalizes on their complementary modes of action. Linagliptin primarily targets postprandial glucose excursions by enhancing insulin secretion and inhibiting glucagon release. Metformin Hydrochloride, on the other hand, primarily addresses fasting hyperglycemia by reducing hepatic glucose output and improving insulin sensitivity. Together, these medications offer comprehensive glycemic control, targeting multiple aspects of glucose homeostasis.\n\nEfficacy in Glycemic Control:\nClinical studies have demonstrated the efficacy of LINALIGLIP M 5/500 in improving glycemic control in patients with T2DM. The combination therapy has been shown to reduce hemoglobin A1c (HbA1c) levels more effectively than either Linagliptin or Metformin Hydrochloride alone. Additionally, the sustained-release formulation of Metformin Hydrochloride in LINALIGLIP M 5/500 provides prolonged and consistent plasma concentrations, resulting in enhanced tolerability and reduced gastrointestinal side effects compared to immediate-release formulations.\n\nSafety Profile:\nBoth Linagliptin and Metformin Hydrochloride are generally well-tolerated medications with established safety profiles. Common side effects associated with Metformin Hydrochloride may include gastrointestinal symptoms such as nausea, diarrhea, or abdominal discomfort, which are often transient and diminish with continued therapy. Linagliptin, in contrast, is not associated with weight gain or an increased risk of hypoglycemia. By combining these agents in LINALIGLIP M 5/500, clinicians can minimize the risk of adverse effects while optimizing therapeutic efficacy.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now:\n", "price": 245.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "SR", "GLP", "risk", "Call", "T2DM", "Email", "500 mg", "action", "nausea", "article", "reduced", "pursuit", "fasting", "activity", "patients", "impaired", "approach", "diarrhea", "contrast", "WhatsApp", "prolonged", "rationale", "biguanide", "management", "clinicians", "other hand", "medications", "information", "weight gain", "hypoglycemia", "Introduction", "LINALIGLIP M", "sterispharma", "HbA1c) levels", "hemoglobin A1c", "Safety Profile", "valuable tools", "adverse effects", "multiple aspects", "Clinical studies", "DPP-4) inhibitor", "Both Linagliptin", "glucagon release", "Linagliptin 5 mg", "continued therapy", "incretin hormones", "insulin secretion", "glucose regulation", "insulin resistance", "two key components", "complementary modes", "Common side effects", "insulin sensitivity", "combination therapy", "glucose homeostasis", "abdominal discomfort", "therapeutic efficacy", "clinical implications", "enhanced tolerability", "combination therapies", "hepatic glucose output", "dipeptidyl peptidase-4", "Synergistic Mechanisms", "glucagon-like peptide-1", "Metformin Hydrochloride", "Type 2 diabetes mellitus", "optimal glycemic control", "individual contributions", "complementary mechanisms", "gastrointestinal symptoms", "peripheral glucose uptake", "postprandial hyperglycemia", "hepatic glucose production", "complex metabolic disorder", "sustained-release formulation", "gastrointestinal side effects", "comprehensive glycemic control", "effective treatment strategies", "immediate-release formulations", "two proven antidiabetic agents", "postprandial glucose excursions", "consistent plasma concentrations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 774, "imageuri": "https://bizimages.withfloats.com/actual/b030c3d3d09044cdb156e98649516547.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/b030c3d3d09044cdb156e98649516547.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-28T13:05:43.085Z", "updatedon": "2024-06-28T13:05:43.085Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/linaliglip-m-5-500-/774", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Linagliptin 5mg and Metformin Hydrochloride (SR) 500mg", "category": "Diabetic Range", "tags": [ "Trajenta Duo", "Ondero Met", "Linapil-M", "Linaglite M", "Saiumet L", "Ligotil-M", "Nexolina M", "Glylina-M", "Diablin M", "Linanext-M" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "667eabca8bfb801f501408f9", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TICAGRACE 60 ", "description": "TICAGRACE 60 \nTicagrelor (60mg)\nTICAGRACE is an antiplatelet medication primarily used to prevent thrombotic events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. It belongs to a class of drugs known as P2Y12 receptor antagonists, which work by inhibiting platelet aggregation, a crucial step in the formation of blood clots. Here are the key aspects of TICAGRACE :\n\nMechanism of Action\nTICAGRACE prevents blood clots by reversibly binding to the P2Y12 receptor on platelets. This action inhibits the ADP (adenosine diphosphate) mediated activation of the GPIIb/IIIa receptor complex, thereby reducing platelet aggregation. Unlike other antiplatelet agents like clopidogrel, TICAGRACE does not require metabolic activation to exert its effects, leading to a more rapid and consistent antiplatelet action.\n\nIndications\nAcute Coronary Syndrome (ACS): TICAGRACE is indicated for patients with ACS, which includes conditions such as unstable angina (UA), non-ST-elevation myocardial infarction (NSTEMI), and ST-elevation myocardial infarction (STEMI). It is often used in combination with aspirin.\nSecondary Prevention of Thrombotic Events: For patients who have had a previous myocardial infarction, TICAGRACE , in combination with aspirin, can be used to reduce the risk of further heart attacks, strokes, and death from a cardiovascular cause.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now:\nhttps://www.sterisonline.com/product/ticagrace-60-133387", "price": 319.0, "discountamount": 96.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "UA", "ACS", "ADP", "60mg", "risk", "drugs", "class", "rapid", "Email", "death", "NSTEMI", "aspirin", "history", "effects", "strokes", "WhatsApp", "patients", "TICAGRACE", "platelets", "formation", "Mechanism", "Ticagrelor", "conditions", "clopidogrel", "Indications", "key aspects", "blood clots", "combination", "sterispharma", "sterisonline", "crucial step", "heart attacks", "unstable angina", "thrombotic events", "cardiovascular cause", "Secondary Prevention", "platelet aggregation", "metabolic activation", "adenosine diphosphate", "antiplatelet medication", "acute coronary syndrome", "other antiplatelet agents", "P2Y12 receptor antagonists", "GPIIb/IIIa receptor complex", "previous myocardial infarction", "consistent antiplatelet action", "ST-elevation myocardial infarction" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 773, "imageuri": "https://bizimages.withfloats.com/actual/ec77acf27f6849249f90d7271eb4b2c5.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/ec77acf27f6849249f90d7271eb4b2c5.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-28T12:25:46.17Z", "updatedon": "2024-06-28T12:25:46.17Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/ticagrace-60-/773", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Ticagrelor (60mg)", "category": "Cardiology range", "tags": [ "Ticagrelor 60 mg generic", "Brilinta 60 mg 180 Tablet Price in India", "Brilinta 60 mg side effects", "Ticagrelor 60 mg Price", "Ticagrelor 60 mg brands in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false }, { "_id": "667ea7dcc03fc717d48ee57f", "fptag": "STERISHEALTHCAREPVTLTDE62F", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROUSTRIN F 20 ", "description": "ROUSTRIN F 20 \nRosuvastatin (20mg), Fenofibron (160mg)\nIntroduction to ROUSTRIN F 20\nROUSTRIN F 20 is a combination medication containing Rosuvastatin (20 mg) and Fenofibrate (160 mg), designed to manage high cholesterol and triglyceride levels effectively. This dual-action therapy combines the benefits of a statin (Rosuvastatin) and a fibrate (Fenofibrate) to provide comprehensive lipid control and reduce the risk of cardiovascular diseases. ROUSTRIN F 20 is particularly beneficial for patients needing aggressive management of dyslipidemia (abnormal lipid levels).\n\nWhat are Rosuvastatin and Fenofibrate?\nOverview of Rosuvastatin\nRosuvastatin is a potent statin that works by inhibiting HMG-CoA reductase, an enzyme crucial for cholesterol synthesis in the liver. By blocking this enzyme, Rosuvastatin reduces the production of cholesterol, leading to lower levels of LDL cholesterol (bad cholesterol) and triglycerides, while increasing HDL cholesterol (good cholesterol).\n\nOverview of Fenofibrate\nFenofibrate is a fibrate that works by activating peroxisome proliferator-activated receptors (PPARs), which play a key role in lipid metabolism. Fenofibrate increases the breakdown and removal of triglycerides from the blood, reduces LDL cholesterol levels, and increases HDL cholesterol levels.\n\nBenefits of ROUSTRIN F 20\nComprehensive Lipid Control\nLowers LDL Cholesterol: ROUSTRIN F 20 significantly reduces levels of LDL cholesterol, helping to decrease the risk of plaque formation in the arteries.\nIncreases HDL Cholesterol: By increasing HDL cholesterol levels, ROUSTRIN F 20 promotes the removal of cholesterol from the bloodstream, offering protective cardiovascular benefits.\nReduces Triglycerides: Fenofibrate in ROUSTRIN F 20 effectively lowers triglyceride levels, contributing to overall lipid balance.\nCardiovascular Protection\nReduces Risk of Heart Disease: Effective lipid management with ROUSTRIN F 20 reduces the risk of heart attacks, strokes, and other cardiovascular events.\nStabilizes Plaques: The combined action of Rosuvastatin and Fenofibrate helps stabilize atherosclerotic plaques, preventing their rupture and the subsequent risk of clot formation.\nImproved Quality of Life\nSymptom Relief: For patients with existing cardiovascular disease, managing lipid levels can alleviate symptoms such as chest pain and improve overall health.\nLong-Term Health: Consistent use of ROUSTRIN F 20 as part of a comprehensive treatment plan can contribute to long-term cardiovascular health and longevity.\nHow to Use ROUSTRIN F 20\nDosage and Administration\nRecommended Dosage: The standard dose of ROUSTRIN F 20 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and medical condition.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistency: For best results, take ROUSTRIN F 20 at the same time each day to maintain consistent blood levels.\nMonitoring: Regularly monitor your cholesterol and triglyceride levels and liver function to ensure the medication is effectively managing your condition. Follow your healthcare provider's instructions regarding blood tests and check-ups.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now:\nhttps://www.sterisonline.com/product/roustrin-f-20-133367", "price": 265.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 0, "_keywords": [ "Call", "part", "food", "PPARs", "Email", "water", "enzyme", "strokes", "rupture", "removal", "key role", "Overview", "symptoms", "patients", "arteries", "WhatsApp", "check-ups", "breakdown", "same time", "longevity", "one tablet", "ROUSTRIN F", "Fenofibron", "full glass", "Guidelines", "Monitoring", "production", "chest pain", "bloodstream", "Fenofibrate", "information", "blood tests", "dyslipidemia", "Introduction", "Rosuvastatin", "instructions", "sterispharma", "best results", "sterisonline", "lower levels", "Heart Disease", "triglycerides", "potent statin", "heart attacks", "standard dose", "overall health", "Consistent use", "Administration", "liver function", "Symptom Relief", "clot formation", "combined action", "subsequent risk", "bad cholesterol", "Long-Term Health", "high cholesterol", "lipid metabolism", "Improved Quality", "good cholesterol", "plaque formation", "HMG-CoA reductase", "medical condition", "Recommended Dosage", "Stabilizes Plaques", "dual-action therapy", "triglyceride levels", "healthcare provider", "individual response", "aggressive management", "overall lipid balance", "abnormal lipid levels", "cholesterol synthesis", "HDL cholesterol levels", "LDL cholesterol levels", "combination medication", "atherosclerotic plaques", "cardiovascular diseases", "Optimal Use Consistency", "consistent blood levels", "Cardiovascular Protection", "Effective lipid management", "other cardiovascular events", "comprehensive lipid control", "comprehensive treatment plan", "long-term cardiovascular health", "existing cardiovascular disease", "protective cardiovascular benefits", "peroxisome proliferator-activated receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 770, "imageuri": "https://bizimages.withfloats.com/actual/fde32d0e34804f2d9ee48cba99f10d95.jpg", "tileimageuri": "https://bizimages.withfloats.com/actual/fde32d0e34804f2d9ee48cba99f10d95.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-28T12:09:00.205Z", "updatedon": "2024-06-28T12:09:00.205Z", "buyonlinelink": null, "producturl": "https://www.sterispharma.com/vizianagaram/medicines/roustrin-f-20-/770", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rosuvastatin (20mg), Fenofibron (160mg)", "category": "Cardiology Range", "tags": [ "Rosuvastatin 10 mg and Fenofibrate 160 mg Tablets IP", "Rosuvastatin and Fenofibrate Tablets Uses", "Rosuvastatin Fenofibrate" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "AssuredPurchase", "producttype": "products", "hsncode": "", "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 10, "query": null, "floatingpoint": null }